Raphael Pharmaceutical Inc.
RAPH· OTC
RAPHRaphael Pharmaceutical Inc.
Filed Aug 13, 2025 · 10-Q · 44 days after period end · 0001213900-25-075662
| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Net Income | -$322.00K | -$248.00K | -$417.00K | -$627.00K |
| EPS Diluted | $0.02 | $0.01 | $0.03 | $0.05 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Raphael Pharmaceutical Inc. · CIK 1415397 · Engraved from SEC EDGAR
ended Jun 30, 2025 · filed Aug 13, 2025 · 44 d after period end
